In vitro evaluation of selected compounds affecting ruminal fermentation and methane production
Journal of Dairy Science · 2026
DOI: 10.3168/jds.2026-28405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dairy Science, 2026. Verfasst von Alice Peres Assumpção und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI 53706. Hauptthemen laut MEDLINE: Methane, Fermentation, Rumen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rumen fermentation yields VFA for host metabolism but also generates methane (CH4), a gaseous byproduct associated with dietary energy losses. Feed additives such as nitro compounds and phytochemicals can reduce CH4 emissions; however, they may also impair VFA synthesis, necessitating careful evaluation before in vivo application. To address this, we conducted 3 sequential in vitro assays to (1) screen 11 compounds for their methane-reducing potential, including nitro compounds, plant secondary compounds, and phytochemicals; (2) identify minimal effective doses (0, 1.25, 2.5, 5, and 10 mM) that promote CH4 reductions without compromising VFA production; and (3) evaluate the combined effects of carvacrol (CAR) and 2-nitroethanol (2NEOH) at low (LC; 1.25 mM each) and high (HC; 2.5 mM each) doses on rumen fermentation parameters, including pH, in vitro dry matter digestibility, VFA profiles, gas production (CH4, CO2, H2), and fermentation kinetics. Of the 11 compounds screened, 4 treatments, including CAR and 2NEOH, significantly reduced CH4 production by at least 20% and were selected for assessment. Increasing dose levels, particularly for CAR, significantly reduced CH4 but also negatively affected VFA production. In the combination phase, the HC dose combination nearly eliminated CH4 production but also reduced total VFA by ~50% and increased H2 accumulation, indicating an overall reduction in microbial fermentation rather than a targeted effect on methanogenesis. The LC dose combination decreased acetic acid concentrations, thus reducing the acetate-to-propionate ratio and H2 accumulation. The decrease in CH4 (18%) and modest increase in propionate did not differ from the control. Our findings indicate that CAR and 2NEOH exert distinct effects on rumen fermentation and methanogenesis. Notably, the high dose combination negatively affected fermentative parameters, whereas the low dose combination performed similarly to 2NEOH alone. Further investigation into how these compounds modulate the rumen microbiota will help to elucidate the mechanisms underlying their differential effects before they can be tested in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI 53706.
- USDA-ARS, US Dairy Forage Research Center, Madison, WI 53706. Electronic address: hcmantovani@wisc.edu.
- USDA-ARS, Food and Feed Safety Research Unit, College Station, TX 77845.
Zitieren
APA
Peres Assumpção, A., Dias Young, J., Machado Ferreira, I., Araujo Rodrigues, A., Anderson, R., & Cuquetto Mantovani, H. (2026). In vitro evaluation of selected compounds affecting ruminal fermentation and methane production. Journal of Dairy Science. https://doi.org/10.3168/jds.2026-28405
Vancouver
Peres Assumpção A, Dias Young J, Machado Ferreira I, Araujo Rodrigues A, Anderson R, Cuquetto Mantovani H. In vitro evaluation of selected compounds affecting ruminal fermentation and methane production. Journal of Dairy Science. 2026. doi:10.3168/jds.2026-28405
BibTeX
@article{PeresAssumpo2026,
author = {Peres Assumpção, Alice and Dias Young, Juliana and Machado Ferreira, Igor and Araujo Rodrigues, Arlan and Anderson, Robin and Cuquetto Mantovani, Hilario},
title = {In vitro evaluation of selected compounds affecting ruminal fermentation and methane production},
journal = {Journal of Dairy Science},
year = {2026},
doi = {10.3168/jds.2026-28405}
}
EUVIMED